The regulatory landscape of ingestible medical devices in the United States
Feature ArticlesLiyamol Sebastian, BPharm
510(k)Approval/marketing authorizationDe novoMedical DevicesPostmarketing requirement/postmarketing commitmentUnited StatesUS Food and Drug Administration (FDA)